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Candida parapsilosis is an important non-albicans
species which infects hospitalized patients. No studies
have correlated outbreak infections of C. parapsilosis with
multiple virulence factors. We used DNA fingerprinting to
determine genetic variability among isolates from a C.
parapsilosis outbreak and from our clinical database. We
compared phenotypic markers of pathogenesis, including
adherence, biofilm formation, and protein secretion (secre-
tory aspartic protease [SAP] and phospholipase). Adher-
ence was measured as colony counts on silicone
elastomer disks immersed in agar. Biofilms formed on
disks were quantified by dry weight. SAP expression was
measured by hydrolysis of bovine albumin; a colorimetric
assay was used to quantitate phospholipase. DNA finger-
printing indicated that the outbreak isolates were clonal
and genetically distinct from our database. Biofilm expres-
sion by the outbreak clone was greater than that of spo-
radic isolates (p < 0.0005). Adherence and protein
secretion did not correlate with strain pathogenicity. These
results suggest that biofilm production plays a role in C.
parapsilosis outbreaks. 
T
he yeast Candida is the fourth most common cause of
hospital-related bloodstream infections (1). Forty per-
cent of patients who have had Candida isolated from their
intravenous catheters have underlying fungemia (2), and
the case-fatality rate for catheter-related candidemia
approaches 40% (3). 
Although C. albicans is the most commonly isolated
yeast, other species are found with increasing frequency,
including C. parapsilosis (4). C. parapsilosis particularly
affects critically ill neonates and surgical intensive care unit
(ICU) patients (5,6), likely because of its association with
parenteral nutrition and central lines (7,8). The affinity of
C. parapsilosis for foreign material is shown by infections
related to peritoneal dialysis catheters (9) and prosthetic
heart valves (10), and this characteristic may be important
in infections of cancer patients with indwelling access
devices (11). C. parapsilosis is increasingly responsible for
hospital outbreaks, and the hands of healthcare workers
may be the predominant environmental source (12).
Our understanding of fungal virulence factors is limit-
ed. The surface adherence capacity of Candida is likely
one such factor, possibly linked to its subsequent ability to
form biofilms (13). Clinically obtained C. albicans isolates
form biofilms (14), which may be important for sustaining
infection. Adhesion (15) and biofilm formation (14) may
be especially important for C. parapsilosis, since
indwelling devices appear to be the predominant route of
infection (8,11). Total parenteral nutrition (TPN) solutions
may promote C. parapsilosis adhesion and growth (16).
Recently, biofilm-forming potential was cited as a reason
that patients with C. parapsilosis-infected catheters should
have the device removed (17). 
Fungi secrete enzymes integral to pathogenesis.
Phospholipases (e.g., phospholipase B) and proteases (e.g.,
secreted aspartyl proteases [SAPs]) are two of the best-
characterized. Although phospholipase B expression has
been well studied in C. albicans (18), the relationship
between C. parapsilosis virulence and phospholipase phe-
notype is unclear. The role of SAP and pathogenesis is
similarly unclear (19).
We characterized genetic and phenotypic characteris-
tics of isolates from a C. parapsilosis outbreak that
occurred in a Mississippi community hospital (20) and
compared these characteristics with those of isolates
obtained from persons with sporadic infections at our
tertiary hospital. We performed molecular characteriza-
tion, comparing C. parapsilosis isolates involved in the
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Methods
Organisms 
Outbreak isolates of C. parapsilosis were obtained at a
Mississippi hospital from April through October 2001.
Epidemiologic details regarding the organisms and
patients have been published elsewhere (21). We examined
five invasive strains (defined as obtained from blood or
catheter cultures: 165, 167, 173, 177, 179), and three envi-
ronmental isolates (from healthcare workers’ hands; 313,
317, and 385). Isolates from sporadic infections were from
the culture collection at the Center for Medical Mycology,
University Hospitals of Cleveland (University Hospitals).
C. parapsilosis strain P/A71 was obtained from sputum,
P92 from blood, and C. albicans M61 from an intravascu-
lar line (19). The site of isolation of other strains is indicat-
ed in the figures. Speciation was performed by using germ
tube tests and API20C-AUX methods. Organism propaga-
tion has been described previously (21). All specimens
were stored and used without patient identifiers, to main-
tain confidentiality.
DNA Fingerprinting 
Isolates were analyzed by Southern blot hybridization
using the complex DNAfingerprinting probe Cp3-13 (22),
according to published methods (23). Genomic DNA was
extracted from cells according to the protocol described by
Scherer and Stevens (24). Three micrograms of DNA
preparation were digested with a combination of EcoRI
and SalI (4 U each per microgram of DNA) for 16 h at
37°C, then underwent electrophoresis at 60 V in a 0.7%
agarose gel. C. parapsilosis strain J940043 was used as a
reference, and its DNAwas run in the first and last lanes of
the fingerprinting gel. The DNA was transferred from the
gel to a nylon Hybond N+ membrane (Amersham,
Piscataway, NJ) by capillary blotting, prehybridized with
sheared salmon sperm DNA, hybridized overnight with
[32P]dCTP-labeled Cp3-13 probe, and viewed by autoradi-
ogram. 
Computer-Assisted Cluster Analysis
The autoradiogram image was digitized, unwarped, and
straightened, by using the DENDRON software database
(25). Processed hybridization patterns were scanned to
identify and link common bands. Patterns underwent pair-
wise comparison: the similarity coefficient (SAB) between
the patterns of every pair of isolates A and B was comput-
ed according to the formula:
SAB=2E/(2E + a + b)
where E is the number of bands common to both strains, a
is the number of bands unique to strain A, and b is the
number of bands unique to strain B (22). The SAB ranges
from 0.0 (no common bands) to 1.0 (identical match of all
bands). Dendrograms based on SAB values were generated
by the unweighted pair-group method with arithmetic
average (UPGMA) (26); values of 0.07 were considered
the threshold for group association (27).
Adherence Assays 
Adherence of C. parapsilosis isolates to silicon elas-
tomer (SE) disks was measured by using a modification of
earlier methods (28); SE was obtained from
Cardiovascular Instrument Corp. (Wakefield, MA) and
prepared as described (14). Standardized suspensions of 50
to 200 cells/mLwere added onto SE disks. Disks were then
washed in phosphate-buffered saline (PBS) to remove non-
adherent cells and placed in wells of 12-well tissue culture
plates (Becton Dickinson, Franklin Lakes, NJ). Two milli-
liters of warm (55°C) liquid SD agar was added per well to
completely cover the SE disks and allowed to solidify.
Plates were incubated overnight (37°C), and colonies
adhering per disk were counted by using a dissecting
microscope. 
Biofilm Formation and Quantitation
C. parapsilosis biofilms were formed on SE disks as
described previously (14). Control disks were handled
identically, except that no blastospores were added.
Biofilm quantitation was performed as described (21) with
dry weight measurements. Dry weight measured total
biofilm mass including fungal cells and extracellular
matrix. 
SAP Assays 
Previous authors have described methods of evaluating
the ability of Candida SAP to degrade bovine serum albu-
men (BSA) from cells grown in SAP expression media
(29). We grew C. parapsilosis isolates in yeast nitrogen
base (YNB) because we could detect SAP activity using
YNB, the use of expression medium resulted in contami-
nating BSA bands, and our assay utilized the same medi-
um used for examining biofilm formation. To confirm
relevance of our findings to those of previous studies, we
examined SAP expression of organisms grown in the
expression medium and found similar results (data not
shown).
After overnight growth, Candida cell suspensions were
centrifuged (6,000 x g for 8 min), and the supernatant was
collected, then concentrated by using a Centricon 10,000
NMWL filter centrifuge (Millipore Corp., Billerica, MA).
Supernatant protein (500 ng) was incubated at 37°C for 15
Candida parapsilosis Characterization
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 6, June 2004 1075min with 0.4 mL of 1% BSA (wt/vol, in 0.1 mol/L citrate
buffer, pH 3.2). After incubation, 10 µL sodium dodecyl
sulfate (SDS) sample buffer and 7 µL of reducing agent
were added to 40 µL of each mixture, and the proteins sol-
ubilized by boiling (10 min). Ten microliters of sample
was separated by SDS–polyacrylamide gel electrophoresis
(PAGE), and the protein bands were visualized by silver
staining (SilverXpress Staining Kit, Invitrogen Corp.,
Carlsbad, CA). The appearance of a 20-kDa band was
indicative of SAP activity. Quantitation of this band was
determined by using QuantOne software v4.3.0 (BioRad
Laboratories, Hercules, CA). Control experiments were
performed by adding either no supernatant (100 µLo f
sodium citrate buffer instead) or supernatant mixed with
protease inhibitor cocktail (Sigma Chemical Co., St. Louis,
MO); 10 µL/mL of supernatant). Protein estimations were
performed by using the BioRad Dc kit (BioRad
Laboratories) and BSA as standard. 
Phospholipase Assays
A colorimetric assay for free fatty acid (FFA) was used
to assess phospholipase activity (30). The incubation mix-
ture for phospholipase (acylhydrolase) activity consisted of
200 µM dipalmitoyl (C16:0) phosphatidylcholine and 200
µmol/L L-palmitoylcarnitine in 0.1% (vol/vol) Triton X-
100. Concentrated culture supernatant was added (100 µg
of total protein), and the mixture made up to a final volume
of 0.25 mL with 0.1 mol/L of sodium citrate, pH 4.0.
Reactions were incubated at 37°C for 1 h, then stopped by
adding chloroform/methanol (1:2, vol/vol). The reaction
products were extracted (31), evaporated to dryness under
nitrogen, and taken up in 50 µL of 0.1% (vol/vol) Triton X-
100. The relative level of free fatty acids in each sample was
determined by using an acyl-CoA-oxidase system assay kit
(Roche Molecular Biochemicals, Indianapolis, IN).
Statistical Analysis 
Adherence and biofilm experiments were performed in
quadruplicate and on separate days. Results for different
isolates were normalized to C. parapsilosis strain 167 to
facilitate meaningful comparisons across multiple experi-
ments (14). Phospholipase and SAP assays were per-
formed at least twice; representative results are shown.
Statistical analysis was performed by using StatView
v5.0.1 software (SAS Institute, Cary, NC); p values < 0.05
were considered significant.
Results
DNA Fingerprinting Analysis
Isolate relatedness was investigated by using the com-
plex DNAfingerprinting probe Cp3-13 (22). We examined
both outbreak strains and our independent University
Hospitals’ isolates to characterize the relatedness of a
range of clinical C. parapsilosis strains. As shown in
Figure 1, the five invasive strains and one of the three envi-
ronmental isolates generated identical patterns. The two
remaining strains (313 and 385) were hand isolates. The
fingerprinting pattern of strain 313 was limited to weak
bands, while none were obtained for 385. The patterns of
the outbreak isolates were also distinct from those of the
University Hospitals’ isolates.
RESEARCH
1076 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 6, June 2004
Figure 1. Genetic analysis of Candida parapsilosis clinical isolates.
Southern blot hybridization patterns of the 14 C. parapsilosis test
isolates were probed with the Cp3-13 DNA fingerprinting probe.
The reference strain J940043 was run in the outer two lanes of the
gel. Isolates associated with the hospital outbreak are indicated.
Note that while isolates 167, 179, 177, 165, 173, and 317 dis-
played identical group I patterns, strains 313 and 385 showed pat-
terns typical of non-group I strains with a lack of abundant intense
bands. Molecular sizes are presented in kilobases to the left of the
panel.Relatedness among outbreak and University Hospitals’
isolates was further assessed through cluster analysis
(Figure 2). The six outbreak isolates with an identical fin-
gerprinting pattern had an SAB value close to 1, whereas the
dendrogram nodes linking the remaining isolates to each
other had an SAB value <0.7, the threshold for relatedness
(27). These analyses showed that the six outbreak isolates
were identical and belonged to group I strains (22). The
remaining isolates appeared moderately related to unrelat-
ed at the genetic level, and therefore were non–group I
strains. Previous studies have shown that Cp3-13 finger-
printing patterns made up of a few weak bands typically
belong to groups II or III, representing a minority of C.
parapsilosis clinical isolates (22,32). However, internally
transcribed spacer region sequencing of strain 313 indi-
cates that it, in fact, belongs to group 1 (D. Warnock, pers.
comm.). Alternately, this finding may suggest past genetic
exchanges between group I and non–group I strains. The
dendrogram also shows that, in addition to being unrelated
to the outbreak isolates, the University Hospitals’ strains
are not related to one another but represent sporadic cases.
Adherence 
Adherence to substrate, whether natural (endothelium)
or artificial (catheter material), is likely the first step in
Candida pathogenesis (33). As shown in Figure 3, the
adherence abilities of C. parapsilosis isolates vary widely.
Adherence was the same for outbreak isolates of the same
clone (167, 165, 173, 317; other clonal isolates were
excluded for clarity), regardless of the site of isolation.
Adherence was significantly higher than for the two unre-
lated hand isolates (313 and 385; p < 0.001). No relation-
ship was found between the outbreak isolates and
University Hospitals’isolates, although the latter exhibited
higher values than strain 313 and 385. Among University
Hospitals’ isolates, no relationship was found between
infection site and adherence.
Biofilm Production 
We first determined the ability of the C. parapsilosis
outbreak isolates to form biofilm. All isolates of the same
clone (strains 167, 165, 177, 179, 173, and 317) showed a
similar pattern of biofilm formation by dry weight (Figure
4A), which suggests that biofilm formation by these iso-
lates is consistent and not site-induced. Except for the unre-
lated environmental strains 313 and 385, biofilm formation
was not significantly different for the various outbreak iso-
lates (p > 0.05, when compared with strain 167). However,
noninvasive strains 313 and 385 produced significantly less
biofilm when measured by dry weight (compared with
strain 167; p < 0.001 for 385 and p = 0.001 for 313).
Figure 4B shows a comparison of biofilm formation by
the C. parapsilosis outbreak clone with isolates obtained
from our University Hospitals’collection, including speci-
mens from different body sites. The outbreak strain 167
produced more biofilm than the University Hospitals’ iso-
lates (p < 0.0005 for comparison of dry weight values of
167 vs. all others), which indicates that outbreak clonal
isolates had a higher ability to form biofilms.
For both sets of isolates, biofilm production was exam-
ined when TPN solution was substituted for YNB medium
because TPN promotes C. parapsilosis growth (16). TPN
increased the dry weight of biofilms formed by the clonal
strain (167) by up to 40% (p = 0.008). However, the pat-
tern of results across strains was similar to YNB-based
method (not shown).
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Figure 2. Relatedness of Candida parapsilosis clinical isolates.
Dendrogram generated from SABs computed for pairwise compar-
isons of the 14 C. parapsilosis test isolates and the reference strain
J940043 fingerprinted with Cp3-13. Note that with the exception of
the six identical outbreak isolates, none of the dendrogram nodes
exceed an SAB value of 0.7 for the other test isolates.
Figure 3. Adherence properties of Candida parapsilosis clinical
isolates. Graph shows adhesion ability of various C. parapsilosis
strains, compared to strain 167 from the University Hospitals of
Cleveland. Results were normalized to strain 167, which was
taken as 100%. Each result is representative of at least two exper-
iments. Error bars represent standard deviation. *p < 0.001 for
comparison of values of strain 167 vs. strains 313 and 385; all
other comparisons had p values > 0.05. (For details of methods
used, see text.) Cath, catheter; Bld, bloodstream; Spt, sputum;
Hnd, hand; Wnd, wound; Pdf, peritoneal dialysis fluid.SAP Assays 
We measured SAPproduction by assaying the ability of
C. parapsilosis supernatant to hydrolyze BSA (29). A rep-
resentative SDS-PAGE gel is shown in Figure 5A. The
appearance of specific digestion products was noted when
culture supernatant was added to BSA. Specifically, we
observed the presence of a 20-kDa product, which did not
appear when the reaction was carried out in presence of a
protease inhibitor cocktail (Figure 5A, lanes marked “+”).
This indicated that the 20-kDa band was a specific by-
product of supernatant protease activity, present in all
supernatants (except for strains M61 and 313). Analysis of
the protease activity of culture supernatants was performed
by densitometric scanning of the 20-kDa band. As seen in
Figure 5B, the intensity of the 20-kDa product varied
greatly between strains and within the outbreak clonal iso-
lates, and no consistent pattern of protease activity was
evident. These results were confirmed in multiple experi-
ments.
Phospholipase Assays
We determined the phospholipase activity of super-
natants obtained from cultures of the different C. parap-
silosis isolates, using a colorimetric assay (30). For
comparative purposes, we included the phospholipase
activity of C. albicans strain M61, since C. albicans is a
known phospholipase producer. Although phospholipase
activity varied among strains (Figure 6), no consistent dif-
ferences were observed between sources (outbreak vs.
University Hospitals), sites (e.g., blood vs. other), or clon-
ality of isolates. 
Discussion
We studied a nosocomial outbreak of C. parapsilosis
(20) and compared outbreak isolates with ones obtained
from sporadic infections at our facility. Genetic analysis
showed the invasive outbreak isolates (defined as being
cultured from blood or catheter [14,34]), as well as at least
one hand isolate, were from the same clone. This finding
agrees with results of previous epidemiologic studies of C.
parapsilosis infections, which found predominant clonali-
ty (10,35). Since these clones were the same as environ-
mental isolates, the outbreaks appear to have a nosocomial
environmental origin. This conclusion also seems to be the
case in the Mississippi outbreak. In contrast, the University
Hospitals’ strains were unrelated, indicating sporadic
infection. Our results support assertions that molecular
analysis is useful in investigating C. parapsilosis out-
breaks (36).
Adhesion is likely a critical first step in yeast pathogen-
esis (33). This property might be expected for C. parap-
silosis, which is thought to be acquired from exogenous
sources, subsequently adheres to indwelling devices, and
finally invades the host. However, our results agree with
those of DeBernardis (37), who found no difference in
adhesion between invasive and skin isolates of C. albicans.
Other studies on C. parapsilosis adherence, in fact,
showed an inverse relationship between invasiveness and
adherence (38). 
The clonal outbreak isolates produced more biofilm
than either the unrelated environmental strains, or the
University Hospitals’ specimens. These results suggest
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Figure 4. Relative dry weight of biofilms formed by Candida para-
psilosis clinical isolates. Panel A shows relative dry weight of the
C. parapsilosis strains from outbreak investigations by the Centers
for Disease Control and Prevention from various culture sources.
Results were normalized to control C. parapsilosis strain 167,
which was taken as 100%. Each result is representative of at least
two experiments. Error bars represent standard deviation. *p =
0.001 and +p < 0.001 for dry weight comparison of 167 vs. 313
and 385, respectively. Panel B shows relative dry weight of the
University Hospitals’ C. parapsilosis strains from various culture
sources, also compared to strain 167. †p < 0.0005 for comparison
of dry weight values of 167 vs. all others. (For details of methods
used, see text.) Cath, catheter; Bld, bloodstream; Spt, sputum;
Hnd, hand; Wnd, wound; Pdf, peritoneal dialysis fluid.that biofilm formation is an important component of an
outbreak strain’s ability to cause infection. Although previ-
ous studies of C. albicans (14) and C. parapsilosis (16,39)
have suggested that bloodstream isolates produce more
biofilm, further in vivo and clinical studies are needed to
confirm these findings. If increased production of biofilm
by outbreak isolates can be confirmed, this finding may
point to a strategy for determining the significance of C.
parapsilosis clinical isolates. Finally, our results confirm
earlier work, suggesting that TPN promotes the develop-
ment of C. parapsilosis biofilms (39).
Although secreted enzymes are likely virulence factors
for all yeast species, patterns of expression vary across
species. This variation may be exemplified by SAP pheno-
types. Although SAPs may play a role in C. albicans adhe-
sion (40), they are not important for the primary mode of
invasion (through gut mucosa) because knockout strains
do not display attenuated virulence (19). However, SAP
may be important for pathogenesis at other sites or stages
of infection. Regarding C. parapsilosis, DeBernardis et al.
(37) found an inverse relationship with invasiveness. Our
findings do not support the concept that SAP expression is
a critical virulence factor for C. parapsilosis. The variabil-
ity of our results even across a single clone also raises a
larger question of the appropriateness of characterizing
SAP expression as a stable experimental pathogenic factor
in C. parapsilosis. Although previous work suggested that
SAPexpression is stable for a given isolate (41), wide vari-
ations exist in relevant mRNAproduction over fairly short
periods (42).
Phospholipases are important virulence factors for C.
albicans (18) but have not been well studied in C. parap-
silosis. Although the isolates examined in this article pro-
duced phospholipase, no correlation was found between
phospholipase activity and site of infection or other viru-
lence factors. Although one article described phospholi-
pase B and protease activity in a few strains of C.
parapsilosis (43), ours is the first study to conduct a more
detailed examination of phospholipase behavior in this
species.
Our results also show no apparent correlations across
the multiple putative virulence factors studied. This result
agrees with Branchini’s examination of genotypic varia-
tion and slime production in C. parapsilosis (44). Other
studies that have reported correlation in expression of mul-
tiple virulence factors have been for C. albicans (45), of
uncertain relevance to C. parapsilosis. 
Although we did not find significant associations
between most of the virulence factors and clinical patho-
logic changes, these results do not mean that these factors
are unimportant. Rather, the results suggest that they are
not critical to clinical outbreaks. Since all isolates
expressed some degree of adhesion (except for hand iso-
lates 313 and 385), SAP, and phospholipase B activity,
these phenotypes may be necessary but not sufficient pre-
requisites for infection. Our results highlight the impor-
tance of using outbreak isolates (rather than those from
sporadic infections or laboratory stocks) in studies of
Candida virulence. Definitive analysis of the role of viru-
lence factors will require further genetic analysis and in
vivo models examining the behavior of knockout mutants
of C. parapsilosis.
This study has some limitations. First, the number of
isolates is small. Given the nature of C. parapsilosis infec-
tions and outbreaks, a higher N could not be expected, and
the outbreak is especially well-characterized (20).
Previous work has drawn conclusions from as few as one
isolate or from less-characterized groups of isolates (16).
Second, genetic analysis of C. parapsilosis that uses Cp3-
13 fingerprinting may have limitations. Third, our SAP
assay is unable to determine the relative contributions of
different members of the gene family, of which there are at
least 10 (46). Such analysis is beyond the scope of this
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Figure 5. Secretory aspartic protease (SAP) expression by
Candida parapsilosis clinical isolates. Panel A shows representa-
tive sodium dodecyl sulfate–polyacrylamide gel electrophoresis of
various C. parapsilosis isolates. M, molecular weight marker lane;
BSA, bovine serum albumin alone; other lanes show number of
isolate; and +, supernatant plus protease inhibitor cocktail.
Protease activity is evident from the appearance of lower molecu-
lar weight bands representing cleavage products. Thick arrow indi-
cates the 20-kDa protein appearing after protease digestion. (For
details of methods used, see text.) Panel B shows densitometric
scanning analysis of SAP activity. Strains 177 and 179 were
included to demonstrate the heterogeneity in SAP production with-
in the clonal strains. Cath, catheter; Bld, bloodstream; Spt, spu-
tum; Hnd, hand; Wnd, wound; Pdf, peritoneal dialysis fluid.paper. Fourth, similar limitations exist regarding character-
ization of phospholipase activity, as Candida expresses
multiple phospholipases (18). Phospholipase expression
varies with environmental conditions (47); however, we
performed experiments under standardized conditions,
physiologic temperature, and using glucose containing
solutions (14). 
In conclusion, the genotypic pattern of this C. parap-
silosis outbreak suggests a clonal outbreak, likely arising
from an environmental source and distinct from sporadic
infection. The outbreak clone produced more biofilm than
all other strains. No clear relationships were apparent for
the other putative virulence factors, which suggests that
they are not critical to outbreak behavior. Further genetic
and in vivo studies are required to confirm these findings.
Future analysis of virulence mechanisms likely needs to
use outbreak strains, as well as taking into account the
interplay of organism, host, and environment.
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